SEC Form 4 · accession 0001209191-15-087315
AGIOS PHARMACEUTICALS, INC. · AGIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis Clayton Cantley Jr.
Director
Period of report
Dec 28, 2015
Accepted (ET)
Dec 29, 2015 · 8:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF2 | Dec 28, 2015 | S | 2,662 | $63.73 | D | 135,637 | D | |
| Common stockF3,F4 | Dec 28, 2015 | S | 2,662 | $63.72 | D | 135,635 | I | See footnote |
| Common stockF5 | Dec 29, 2015 | S | 2,670 | $66.16 | D | 132,967 | D | |
| Common stockF6,F4 | Dec 29, 2015 | S | 2,670 | $66.11 | D | 132,965 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $62.34 to $64.58. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $62.34 to $64.68. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4Shares held by Vicki Lee Sato, who is the reporting person's spouse.
- F5The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $63.86 to $67.49. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F6The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $63.86 to $67.26. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.